669 related articles for article (PubMed ID: 28783948)
41. Design, synthesis and biological activity of 1H-indene-2-carboxamides as multi-targeted anti-Alzheimer agents.
Koca M; Yerdelen KO; Anil B; Kasap Z; Sevindik H; Ozyurek I; Gunesacar G; Turkaydin K
J Enzyme Inhib Med Chem; 2016; 31(sup2):13-23. PubMed ID: 27226239
[TBL] [Abstract][Full Text] [Related]
42. Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as multi-targeted compounds against Alzheimer's disease.
Zhang C; Du QY; Chen LD; Wu WH; Liao SY; Yu LH; Liang XT
Eur J Med Chem; 2016 Jun; 116():200-209. PubMed ID: 27061983
[TBL] [Abstract][Full Text] [Related]
43. 2,4-Disubstituted quinazolines as amyloid-β aggregation inhibitors with dual cholinesterase inhibition and antioxidant properties: Development and structure-activity relationship (SAR) studies.
Mohamed T; Rao PPN
Eur J Med Chem; 2017 Jan; 126():823-843. PubMed ID: 27951490
[TBL] [Abstract][Full Text] [Related]
44. Novel Tacrine-Based Pyrano[3',4':5,6]pyrano[2,3-b]quinolinones: Synthesis and Cholinesterase Inhibitory Activity.
Hariri R; Afshar Z; Mahdavi M; Safavi M; Saeedi M; Najafi Z; Sabourian R; Karimpour-Razkenari E; Edraki N; Moghadam FH; Shafiee A; Khanavi M; Akbarzadeh T
Arch Pharm (Weinheim); 2016 Dec; 349(12):915-924. PubMed ID: 27910192
[TBL] [Abstract][Full Text] [Related]
45. Multiple Ligands Targeting Cholinesterases and β-Amyloid: Synthesis, Biological Evaluation of Heterodimeric Compounds with Benzylamine Pharmacophore.
Szałaj N; Bajda M; Dudek K; Brus B; Gobec S; Malawska B
Arch Pharm (Weinheim); 2015 Aug; 348(8):556-63. PubMed ID: 26032855
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and biological evaluation of berberine-thiophenyl hybrids as multi-functional agents: Inhibition of acetylcholinesterase, butyrylcholinesterase, and Aβ aggregation and antioxidant activity.
Su T; Xie S; Wei H; Yan J; Huang L; Li X
Bioorg Med Chem; 2013 Sep; 21(18):5830-40. PubMed ID: 23932451
[TBL] [Abstract][Full Text] [Related]
47. Design, synthesis, biological evaluation, and molecular modeling studies of chalcone-rivastigmine hybrids as cholinesterase inhibitors.
Wang L; Wang Y; Tian Y; Shang J; Sun X; Chen H; Wang H; Tan W
Bioorg Med Chem; 2017 Jan; 25(1):360-371. PubMed ID: 27856236
[TBL] [Abstract][Full Text] [Related]
48. Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's disease.
Zaręba P; Łątka K; Mazur G; Gryzło B; Pasieka A; Godyń J; Panek D; Skrzypczak-Wiercioch A; Höfner GC; Latacz G; Maj M; Espargaró A; Sabaté R; Jóźwiak K; Wanner KT; Sałat K; Malawska B; Kulig K; Bajda M
Eur J Med Chem; 2023 Dec; 261():115832. PubMed ID: 37837674
[TBL] [Abstract][Full Text] [Related]
49. Design, synthesis, and activity evaluation of novel multitargeted l-tryptophan derivatives with powerful antioxidant activity against Alzheimer's disease.
Zeng X; Cheng S; Li H; Yu H; Cui Y; Fang Y; Yang S; Feng Y
Arch Pharm (Weinheim); 2024 May; 357(5):e2300603. PubMed ID: 38290060
[TBL] [Abstract][Full Text] [Related]
50. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
[TBL] [Abstract][Full Text] [Related]
51. 1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer's disease.
Wichur T; Więckowska A; Więckowski K; Godyń J; Jończyk J; Valdivieso ÁDR; Panek D; Pasieka A; Sabaté R; Knez D; Gobec S; Malawska B
Eur J Med Chem; 2020 Feb; 187():111916. PubMed ID: 31812794
[TBL] [Abstract][Full Text] [Related]
52. New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease.
El-Sayed NF; El-Hussieny M; Ewies EF; Fouad MA; Boulos LS
Bioorg Chem; 2020 Jan; 95():103499. PubMed ID: 31838287
[TBL] [Abstract][Full Text] [Related]
53. A multifunctional anti-AD approach: Design, synthesis, X-ray crystal structure, biological evaluation and molecular docking of chrysin derivatives.
Yang A; Liu C; Zhang H; Wu J; Shen R; Kou X
Eur J Med Chem; 2022 Apr; 233():114216. PubMed ID: 35227980
[TBL] [Abstract][Full Text] [Related]
54. Novel N-benzylpiperidine derivatives of 5-arylisoxazole-3-carboxamides as anti-Alzheimer's agents.
Saeedi M; Felegari P; Iraji A; Hariri R; Rastegari A; Mirfazli SS; Edraki N; Firuzi O; Mahdavi M; Akbarzadeh T
Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000258. PubMed ID: 33226157
[TBL] [Abstract][Full Text] [Related]
55. Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors.
Hamulakova S; Janovec L; Hrabinova M; Spilovska K; Korabecny J; Kristian P; Kuca K; Imrich J
J Med Chem; 2014 Aug; 57(16):7073-84. PubMed ID: 25089370
[TBL] [Abstract][Full Text] [Related]
56. Discovery of novel isoflavone derivatives as AChE/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling.
Feng B; Li X; Xia J; Wu S
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):968-977. PubMed ID: 28718678
[TBL] [Abstract][Full Text] [Related]
57. Novel deoxyvasicinone derivatives as potent multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation.
Ma F; Du H
Eur J Med Chem; 2017 Nov; 140():118-127. PubMed ID: 28923380
[TBL] [Abstract][Full Text] [Related]
58. Rational Design and Multibiological Profiling of Novel Donepezil-Trolox Hybrids against Alzheimer's Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties.
Cai P; Fang SQ; Yang XL; Wu JJ; Liu QH; Hong H; Wang XB; Kong LY
ACS Chem Neurosci; 2017 Nov; 8(11):2496-2511. PubMed ID: 28806057
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses.
Kamal MA; Shakil S; Nawaz MS; Yu QS; Tweedie D; Tan Y; Qu X; Greig NH
CNS Neurol Disord Drug Targets; 2017; 16(7):820-827. PubMed ID: 28176640
[TBL] [Abstract][Full Text] [Related]
60. Diosmetin derivatives as multifunctional anti-AD ligands: Design, synthesis, and biological evaluation.
Yang A; Yi X; Zhang H; Shen R; Kou X
Chem Biol Drug Des; 2024 Apr; 103(4):e14529. PubMed ID: 38670598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
